Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Poor oral health tied to much higher risk of heart attack, stroke
Regularly going to the dentist, researchers added, may reduce cardiovascular risks by a significant margin.
PCI for eruptive calcified nodules: Drug-eluting stents, drug-coated balloons both linked to poor outcomes
In some cases, researchers noted, CABG may be a better treatment option. The group emphasized that alternative therapies are still needed to improve patient care.
Judge files lawsuit over husband’s death—alleges heart symptoms were mismanaged
The patient reported chest pain multiple times and had a family history of heart disease. According to the lawsuit, however, he was never referred to a cardiologist.
Most adults know nothing about CKM syndrome—but it impacts nearly everyone
Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.
FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

Vitamins for CVD prevention? Not so fast, says USPSTF

According to new recommendations from the USPSTF, there are two specific vitamins—vitamin E and beta-carotene—that should not be taken to prevent CVD. When it comes to other vitamins, however, more evidence is still needed.

Predicting the impact of new heart attack medications

The study's authors hope their equations can make a significant impact on patient care in the years ahead.

Seeing the future: How routine eye exams could predict heart attacks

Researchers presented their findings at the 2022 European Human Genetics Conference in Vienna.

Risk of dementia skyrockets when patients have more than 1 cardiovascular condition

“Many studies look at the risk of a single condition in relation to dementia, but health is more complex than that,” one researcher said.

Dragonfly OpStar Imaging Catheter FDA recall May 2022

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

There have been five reported incidents so far, including one patient injury.

Example of ultrasound-assisted laser arterial plaque removal, which might be developed into a new type of less traumatic atherectomy system.Image courtesy of Rohit Singh.

New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque.

How cardiologists can make an impact in the face of anti-abortion laws

“For patients with cardiovascular disease, abortion access is a critical part of their comprehensive cardiovascular and reproductive care,” according to the three authors of a new commentary piece in JAMA Cardiology.

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD Disrupt PAD Disrupt CAD SCAI 2022

Intravascular lithotripsy tied to superior long-term PAD, PCI outcomes at SCAI 2022

Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

Acute Coronary Syndromes

Poor oral health tied to much higher risk of heart attack, stroke

PCI for eruptive calcified nodules: Drug-eluting stents, drug-coated balloons both linked to poor outcomes

Judge files lawsuit over husband’s death—alleges heart symptoms were mismanaged

Most adults know nothing about CKM syndrome—but it impacts nearly everyone

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes